Acumen Pharmaceuticals, Inc. (ABOS)
NASDAQ: ABOS · Real-Time Price · USD
1.880
0.00 (0.00%)
At close: Oct 8, 2025, 4:00 PM EDT
1.860
-0.020 (-1.06%)
After-hours: Oct 8, 2025, 7:06 PM EDT
Acumen Pharmaceuticals Market Cap
Acumen Pharmaceuticals has a market cap or net worth of $113.88 million as of October 8, 2025. Its market cap has decreased by -24.18% in one year.
Market Cap
113.88M
Enterprise Value
-21.58M
1-Year Change
-24.18%
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on July 1, 2021, Acumen Pharmaceuticals's market cap has decreased from $618.43M to $113.88M, a decrease of -81.59%. That is a compound annual growth rate of -32.71%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 113.88M | 10.20% |
| Dec 31, 2024 | 103.34M | -53.53% |
| Dec 29, 2023 | 222.38M | 0.62% |
| Dec 30, 2022 | 221.00M | -19.22% |
| Dec 31, 2021 | 273.58M | -55.76% |
| Jul 1, 2021 | 618.43M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 761.94B |
| Johnson & Johnson | 453.37B |
| AbbVie | 405.83B |
| UnitedHealth Group | 327.10B |
| Novo Nordisk | 264.73B |
| AstraZeneca | 264.35B |
| Novartis AG | 256.18B |
| Abbott Laboratories | 233.03B |